Ontology highlight
ABSTRACT: Background
Although tranexamic acid (TXA), a readily accessible antifibrinolytic agent, is widely adopted in hemorrhage scenarios, its role on mortality in patients with hemoptysis remains uncertain. New evidence is yet to be generated to evaluate the risk of mortality after using TXA in patients with hemoptysis.Methods
PubMed, EMBASE, Cochrane Library, Web of Science, and Scopus databases were searched from inception to May 2020. Randomized controlled trials and observational studies that evaluated the effect of TXA on patients with hemoptysis were included. Data were independently extracted by 2 reviewers and synthesized using a random-effects model.Main results
Five studies with a total of 20,047 patients were analyzed. When compared with the control, administrat
SUBMITTER: Chen LF
PROVIDER: S-EPMC8137080 | biostudies-literature | 2021 May
REPOSITORIES: biostudies-literature